1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cv 6209 in 115 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cv 6209) | Trials (cv 6209) | Recent Studies (post-2010) (cv 6209) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 133 | 0 | 2 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | cv 6209 (IC50) |
---|---|---|---|
Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | 0.033 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (11.30) | 18.7374 |
1990's | 86 (74.78) | 18.2507 |
2000's | 15 (13.04) | 29.6817 |
2010's | 1 (0.87) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirano, T; Manabe, T | 1 |
Bates, EJ; Ferrante, A; Kowanko, IC | 1 |
Hisayama, T; Kondoh, W; Miyano, H; Moritoki, H; Takeuchi, S | 1 |
Iwamoto, I; Matsumura, R; Nakajima, H; Takatsu, K; Tomioka, H; Tomoe, S; Yoshida, S | 1 |
Inada, M; Iwasaka, T; Sugiura, T; Takayama, Y; Taniguchi, H | 1 |
Mori, K; Nishizawa, F; Ozawa, K; Shimahara, Y; Takada, Y; Yamaguchi, T; Yamaoka, Y | 1 |
Kondo, M; Naito, Y; Takahashi, S; Tanigawa, T; Ueda, S; Yoshida, N; Yoshikawa, T | 1 |
Gotoh, M; Kanai, T; Monden, M; Mori, T; Nakano, H; Ukei, T; Umeshita, K; Wang, KS | 1 |
Binnaka, T; Fujimura, K; Inoue, K; Kitagawa, S; Kubota, Y; Mizuno, T; Tani, K; Yamaguchi, T | 1 |
Bates, EJ; Ferrante, A; Harvey, DP | 1 |
Asaka, M; Entani, C; Fujita, M; Iida, H; Izumino, K; Sasayama, S; Takata, M | 1 |
Imanishi, N; Morooka, S; Uchida, M | 1 |
Fukumura, D; Imaeda, H; Kurose, I; Miura, S; Nagata, H; Sekizuka, E; Shiozaki, H; Suematsu, M; Tashiro, H; Tsuchiya, M | 1 |
Lim, WH; Stewart, AG | 1 |
Hu, WM; Man, RY | 1 |
Harris, T; Stewart, AG | 1 |
Kondo, M; Naito, Y; Takahashi, S; Tanigawa, T; Yoshida, N; Yoshikawa, T | 1 |
Forn, J; García-Rafanell, J; Gómez, LA; Merlos, M; Vericat, L | 1 |
Fukumura, D; Kurose, I; Miura, S; Nagata, H; Sekizuka, E; Suematsu, M; Tsuchiya, M | 1 |
Imura, Y; Kawamura, M; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S | 1 |
Bergström, M; Carlsson, J; Gáti, I; Långström, B; Muhr, C | 1 |
Goto, T; Hibino, A; Mimura, K; Mori, Y; Mune, M; Nishikawa, O; Nomoto, H; Okada, K; Sonobe, M; Yukawa, S | 1 |
Ehrlich, YH; Kornecki, E | 1 |
Ikeda, I; Oda, M; Sakakura, M; Yasunaga, K | 1 |
Hoshihara, Y; Miyamoto, T; Nogami, M; Shiga, J; Tabuchi, M; Tsubura, K; Yamamoto, T | 1 |
Hayashi, M; Imai, Y; Oh-ishi, S | 1 |
Imura, Y; Maezaki, N; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S | 1 |
Bergström, M; Carlsson, J; Gáti, I; Muhr, C | 1 |
Guntaka, RV; Kandala, JC; Lim, RW; Shukla, SD; Tripathi, YB | 1 |
Imanishi, M; Miura, K; Okumura, M; Shimmen, T; Yamamoto, K; Yamanaka, S; Yamashita, Y; Yukimura, T | 1 |
Arita, Y; Furukawa, M; Kimura, T; Nawata, H; Sumii, T; Takano, S; Yamaguchi, H | 1 |
Blumenthal, RN; Kirchhoff, CF; Leff, AR; Munoz, NM; Strek, ME | 1 |
Inoue, Y; Kohno, S; Miyazaki, T; Yamaguchi, K | 1 |
Ando, M; Matsuura, S; Suginami, H | 1 |
Akutsu, I; Amagai, M; Fukuda, T; Makino, S; Motojima, S; Numao, T | 1 |
Fukuoka, T | 1 |
Aoki, S; Kurosawa, M; Tsukagoshi, H | 1 |
Miyamoto, T; Nogami, M; Suko, M | 1 |
Binnaka, T; Hirohara, J; Kubota, Y; Mizuno, T; Sameshima, Y; Yamaguchi, T | 1 |
Midorikawa, Y; Ogata, H | 1 |
Fukuoka, T; Hisanaga, M; Kanehiro, H; Matsumoto, M; Nakajima, Y; Nakano, H; Segawa, M; Wada, T | 1 |
Kurihara, H; Masaki, T; Morita, T; Oh-hashi, Y; Sugiyama, T; Takaku, F; Yamashita, T; Yanagisawa, M; Yazaki, Y; Yoshizumi, M | 1 |
Lefer, AM; Stahl, GL; Terashita, Z | 2 |
Dhar, A; Morrison, WJ; Shukla, SD | 1 |
Morrison, WJ; Shukla, SD | 1 |
Hawley, SB; Nieves, AL; Spada, CS; Williams, LS; Woodward, DF | 1 |
Stewart, AG | 1 |
Kamata, K; Kasuya, Y; Mori, T; Shigenobu, K | 1 |
Kondo, K; Takayasu, M; Terao, S | 1 |
Imura, Y; Iwasaki, K; Nishikawa, K; Shibouta, Y; Terashita, Z | 1 |
Imura, Y; Nishikawa, K; Takatani, M; Tasaka, A; Terashita, Z; Tsushima, S; Yoshioka, Y | 1 |
Bitterman, H; Lefer, AM; Stahl, GL; Terashita, Z | 1 |
Fukuoka, T; Matsumoto, M; Nakajima, Y; Nakano, H; Shiratori, T | 1 |
Imura, Y; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S | 1 |
Fukumura, D; Ishii, H; Kimura, H; Kurose, I; Miura, S; Morishita, T; Nagata, H; Suzuki, M; Tsuchiya, M | 1 |
Iwamoto, I; Tomioka, H; Tomoe, S; Yoshida, S | 1 |
Iwamoto, I; Tomoe, S; Yoshida, S | 1 |
Nieves, AL; Spada, CS; Tuckett, RP; Williams, LS; Woodward, DF | 1 |
Arai, Y; Kamata, K; Kasuya, Y | 1 |
Chiyotani, A; Isono, K; Kondo, M; Konno, K; Ozawa, Y; Takeuchi, S; Tamaoki, J | 1 |
Kumagai, H; Nakayama, R; Saito, K | 1 |
Fukutomi, M; Kawachi, K; Kitamura, S; Taniguchi, S; Yoshida, Y | 1 |
Fukumura, D; Kai, A; Kudoh, Y; Kurose, I; Miura, S; Suematsu, M; Suzuki, H; Tashiro, H; Tsuchiya, M; Yoshioka, M | 1 |
Altavilla, D; Bussolino, F; Calapai, G; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Saitta, A; Squadrito, F; Zingarelli, B | 1 |
Gupta, JB; Kalra, J; Prasad, K; Prasad, M | 1 |
Aosaki, N; Minezaki, K; Nakamura, H; Nakazawa, H; Ohsuzu, F; Senoh, M; Tuji, C | 1 |
Inoue, K; Kitajima, T; Kubota, Y; Okuhira, M; Tani, K; Yamada, H; Yamaguchi, T | 1 |
Gotoh, M; Kanai, T; Monden, M; Mori, T; Ukei, T; Umeshita, K; Wang, KS | 1 |
Ikeda, M; Komatz, Y; Muguruma, K; Saito, K; Sugimoto, T | 1 |
Endo, S; Hirashima, Y; Karasawa, K; Nojima, S; Otsuji, T; Takaku, A | 1 |
Aomatsu, Y; Fukuoka, T; Horikawa, M; Ko, S; Nakajima, Y; Nakano, H; Ueno, M; Yoshimura, A | 1 |
Fukumura, D; Imaeda, H; Kurose, I; Miura, S; Sekizuka, E; Serizawa, H; Shiozaki, H; Suematsu, M; Tashiro, H; Tsuchiya, M | 1 |
Goto, Y; Hayashi, K; Mori, T; Nishi, O; Tominaga, T | 1 |
Fukumura, D; Ishii, H; Kurose, I; Miura, S; Tsuchiya, M | 1 |
Inoue, K; Kubota, Y; Ogura, M | 1 |
Kamata, K; Kasuya, Y; Numazawa, T | 1 |
Feinmark, SJ; Guo, SD; Hoffman, BF | 2 |
Enzan, K; Inaba, H; Kurosawa, S; Yoshioka, N | 1 |
Igarashi, Y; Kurosawa, M; Miyachi, Y; Tsukagoshi, H | 1 |
Hamada, M; Hiroshiba, N; Honda, Y; Miyamoto, K; Nishiwaki, H; Ogura, Y | 1 |
Endo, S; Hirashima, Y; Nogami, K; Takaku, A | 1 |
Martin, SL; Morse, DS; Stahl, GL | 1 |
Imagawa, M; Mimata, H; Nakagawa, M; Nomura, Y; Ogata, J; Takahashi, S | 1 |
Cromie, WJ; Leff, AR; Palmer, JS; Plzak, LF | 1 |
Friedman, E; Shi, LC; Wang, HY | 1 |
English, JC; Feeley, EJ; Nikbakht-Sangari, M; Poostizadeh, A; Qayumi, KA | 1 |
Ichinowatari, G; Ohuchi, K; Tanimoto, A; Yaginuma, H; Yamada, M | 2 |
Francescangeli, E; Goracci, G; Grassi, S; Pettorossi, VE | 1 |
Enzan, K; Mitsuhata, H; Shouji, K; Yoshioka, N | 1 |
Kitamura, M; Minamiya, Y; Ogawa, J; Saito, S; Tozawa, K | 1 |
Harada, M; Kimura, S; Nagata, M; Takeuchi, M; Watanabe, A | 1 |
Gillespie, K; Jamieson, WR; Marier, JR; McGibbon, R; Mickleson, H; Sadeghi, H; Zhang, J | 1 |
Bartemes, KR; Gleich, GJ; Kita, H; McKinney, S | 1 |
Kotani, Y; Nishimura, Y; Shan, L; Yokoyama, M | 1 |
Albini, A; Biancone, L; Boccellino, M; Bussolati, B; Camussi, G; Cantaluppi, V; Conaldi, PG; Del Sorbo, L; Toniolo, A | 1 |
Bulkley, GB; Fuh, KC; Klein, AS; Maemura, K; Meneshian, A; Owaki, T; Takao, S; Wang, D | 1 |
Goldman, R; Moshonov, S; Zor, U | 1 |
Akutsu, A; Hayakawa, S; Hirano, H; Imai, T; Ishii, K; Nakahara, T; Shigenobu, K; Tanaka, H; Tanaka, Y | 1 |
Fietzner, K; Fink, L; Grimminger, F; Hattar, K; Himmel, B; Seeger, W; Sibelius, U | 1 |
Ibe, BO; Raj, JU | 1 |
Gokorsch, S; Grimminger, F; Krüll, M; Lohmeyer, J; Mayer, K; Merfels, M; Muhly-Reinholz, M; Rosseau, S; Schwarzer, N; Seeger, W; Suttorp, N | 1 |
Lee, RK; Teather, LA; Wurtman, RJ | 1 |
Choi, EK; Choi, IW; Choi, JH; Han, SJ; Im, SY; Ko, HM; Lee, HK; Lee, HS; Seo, KH | 1 |
Houghton, TJ; Lambertino, AT; Leff, AR; McGilvra, JD; Rawal, VH; Xu, C; Zhu, X | 1 |
Aikawa, T; Hirose, T; Matsumoto, I; Shimada, T | 1 |
Arthur, JR; McLeod, E; Sneddon, AA; Wahle, KW | 1 |
Ahmed, AK; Aosai, F; Fang, H; Furuya, M; Mun, HS; Norose, K; Yano, A | 1 |
Dessaint, JP; Devos, P; Dussart, P; Dutoit, V; El Behi, M; Lefranc, D; Prin, L; Vermersch, P; Zéphir, H | 1 |
Day, JR; Ghimire, G; Leong, HS; Mahesh, BM; McCormack, AD; Podor, TJ; Rose, ML; Smith, JD | 1 |
Cui, S; Kurata, Y; Liu, W; Shibamoto, T; Takano, H; Zhang, W | 1 |
Boon, L; Galli, SJ; Mantegazza, R; Musio, S; Ohtsu, H; Pedotti, P; Pedotti, R; Steinman, L | 1 |
Kuda, Y; Kurata, Y; Shibamoto, T; Tanida, M; Wang, M | 1 |
115 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cv 6209
Article | Year |
---|---|
"Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis.
Topics: Acute Disease; Allopurinol; Animals; Ceruletide; Drug Therapy, Combination; Gabexate; Male; Pancreatitis; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Xanthine Oxidase | 1992 |
Platelet-activating factor inhibits proteoglycan synthesis and enhances neutrophil-mediated proteoglycan degradation in cartilage explants.
Topics: Animals; Azepines; Cartilage, Articular; Cattle; Cells, Cultured; Granulocyte-Macrophage Colony-Stimulating Factor; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfur Radioisotopes; Triazoles; Tumor Necrosis Factor-alpha | 1992 |
Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
Topics: Aging; Animals; Aorta, Thoracic; Arginine; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Hemoglobins; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 1992 |
CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea.
Topics: Administration, Inhalation; Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Cromolyn Sodium; Eosinophils; Evaluation Studies as Topic; Hypersensitivity, Delayed; Injections, Intraperitoneal; Interleukin-5; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Pyridinium Compounds; T-Lymphocytes, Regulatory; Trachea | 1992 |
Role of platelet-activating factor in pulmonary edema after coronary ligation in dogs.
Topics: Animals; Coronary Circulation; Coronary Vessels; Dogs; Extravascular Lung Water; Hemodynamics; Ligation; Myocardial Infarction; Platelet Activating Factor; Pulmonary Edema; Pyridinium Compounds | 1992 |
Protective effect of platelet-activating factor antagonist on hepatic energy metabolism following transient hepatic inflow occlusion in rabbits.
Topics: Animals; Disease Models, Animal; Energy Metabolism; Ischemia; Ketone Bodies; Lactates; Liver; Male; Mitochondria, Liver; Platelet Activating Factor; Portal System; Pyridinium Compounds; Rabbits | 1992 |
Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion.
Topics: Animals; Gastric Mucosa; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Vitamin E | 1992 |
Protective effects of a PAF antagonist against liver injury induced by warm ischemia or cold preservation.
Topics: Animals; Bile; Ischemia; Liver Transplantation; Organ Preservation; Perfusion; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Temperature | 1992 |
Burn-induced gastric mucosal hemodynamic disturbance in the rat. Role of platelet-activating factor.
Topics: Animals; Azepines; Blood Pressure; Burns; Gastric Mucosa; Hemodynamics; Hemoglobins; Male; Oxygen; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Regional Blood Flow; Thiazoles; Thiazolidines; Triazoles | 1992 |
Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988.
Topics: Azepines; Cell Degranulation; Cell Survival; Humans; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds; Respiratory Burst; Triazoles | 1992 |
Effects of the platelet-activating factor antagonists CV-6209 and CV-3988 on nephrotoxic serum nephritis in the rat.
Topics: Animals; Anions; Basement Membrane; Binding Sites; Kidney Glomerulus; Male; Nephritis; Phospholipid Ethers; Platelet Activating Factor; Proteinuria; Pyridinium Compounds; Rats; Rats, Inbred Strains | 1992 |
Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine.
Topics: Anaphylaxis; Animals; Asthma; Bronchi; Guinea Pigs; Histamine; Male; Ovalbumin; Platelet Activating Factor; Platelet Count; Pyridinium Compounds; Respiratory Function Tests; SRS-A; Thiazoles; Thiazolidines | 1992 |
Role of platelet activating factor on the fibrinolytic activation in the pathogenesis of gastric mucosal damage induced by endothelin-1.
Topics: Animals; Dose-Response Relationship, Drug; Endothelins; Fibrinolysis; Gastric Mucosa; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Time Factors; Tissue Plasminogen Activator | 1992 |
Regulation of eicosanoid generation in activated macrophages.
Topics: Animals; Azepines; Dexamethasone; Epoprostenol; Macrophage Activation; Macrophages; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1991 |
Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart.
Topics: Animals; Azepines; Coronary Vessels; Heart; In Vitro Techniques; Indoles; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles; Vasoconstriction; Vasodilation | 1991 |
Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.
Topics: Animals; Arachidonic Acid; Azepines; Blood Platelets; Calcimycin; Chloroquine; Female; Kinetics; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Signal Transduction; Superoxides; Tetradecanoylphorbol Acetate; Triazoles | 1991 |
Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.
Topics: Calcimycin; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Kinetics; Luminescent Measurements; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; Superoxides | 1991 |
Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Carrageenan; Dextrans; Edema; Histamine Antagonists; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Serotonin Antagonists; Zymosan | 1990 |
Involvement of platelet-activating factor in endothelin-induced vascular smooth muscle cell contraction.
Topics: Animals; Calcium; Cell Line; Endothelins; Fura-2; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Splanchnic Circulation; Vasoconstriction | 1991 |
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles | 1992 |
Application of (methyl-11C)-methionine in the multicellular spheroid system.
Topics: Benzeneacetamides; Benzoquinones; Carbon Radioisotopes; Cell Aggregation; Cell Line; Cycloheximide; Humans; Hydroxamic Acids; In Vitro Techniques; Lipoxygenase Inhibitors; Methionine; Platelet Activating Factor; Pyridinium Compounds; Tumor Cells, Cultured | 1991 |
Effect of platelet-activating factor on lipoprotein lipase and blood lipids.
Topics: Animals; Cholesterol; Kinetics; Lipase; Lipids; Lipolysis; Lipoprotein Lipase; Male; Phospholipids; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reference Values; Triglycerides | 1991 |
Calcium ion mobilization in neuronal cells induced by PAF.
Topics: Adenosine Triphosphate; Animals; Brain; Calcium; Cell Line; Cells, Cultured; Cerebral Cortex; Corpus Striatum; Embryo, Mammalian; Glioma; Kinetics; Mice; Mice, Inbred Strains; Neuroblastoma; Neurons; PC12 Cells; Phospholipid Ethers; Platelet Activating Factor; Prenylamine; Pyridinium Compounds; Rats; Synaptosomes | 1991 |
Presence of platelet-activating factor in pyuria in humans.
Topics: Animals; Chromatography, Thin Layer; Humans; Kinetics; Phospholipid Ethers; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Pyuria; Rabbits | 1991 |
The effect of CV-3988 and CV-6209 on the acute gastric erosions of rats due to water-immersion and restraint stress.
Topics: Analysis of Variance; Animals; Gastric Mucosa; Immersion; Indomethacin; Male; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Restraint, Physical; Stomach; Stomach Ulcer; Stress, Physiological | 1991 |
Involvement of platelet-activating factor in zymosan-induced rat pleurisy.
Topics: Animals; Cyproheptadine; Eosinophils; Inflammation; Leukocytes; Male; Mast Cells; Neutrophils; Platelet Activating Factor; Pleurisy; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Zymosan | 1991 |
Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
Topics: Animals; Azepines; Humans; Isoquinolines; Molecular Structure; Niacinamide; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines; Triazoles | 1991 |
Effects of the PAF-analog and -antagonist CV-6209 on cultured human glioma cell lines.
Topics: Cell Division; Cell Line; Cell Survival; DNA Replication; Glioma; Humans; Kinetics; Methionine; Neuroglia; Platelet Activating Factor; Pyridinium Compounds; Thymidine | 1991 |
Platelet activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells.
Topics: Cycloheximide; Gene Expression Regulation, Neoplastic; Genes, fos; Humans; Kinetics; Platelet Activating Factor; Pyridinium Compounds; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1991 |
Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Endothelins; Female; Femoral Artery; Heart Rate; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney; Male; Platelet Activating Factor; Prostaglandins; Pyridinium Compounds; Renal Circulation; Time Factors; Vasoconstriction | 1991 |
Role of endogenous platelet-activating factor(PAF) in stress-induced hemorrhagic pancreatitis in rats.
Topics: Animals; Ceruletide; Male; Pancreatitis; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stress, Physiological | 1991 |
Effects of PAF on isolated rat airways perfused with blood-free solution.
Topics: Acetylcholine; Animals; Blood; Bronchi; Dose-Response Relationship, Drug; In Vitro Techniques; Lung; Male; Muscle Contraction; Muscle, Smooth; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Pyridinium Compounds; Rats; Rats, Inbred Strains; Regional Blood Flow; Tachyphylaxis | 1991 |
Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats.
Topics: Animals; Antithrombin III; Disseminated Intravascular Coagulation; Endotoxins; Kidney; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Sepsis; Toxemia | 1991 |
Pregnancy suppression by a structurally related antagonist for platelet activating factor, CV-6209, in mice.
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Embryonic and Fetal Development; Embryonic Development; Female; Mice; Mice, Inbred ICR; Platelet Activating Factor; Platelet Count; Pregnancy; Pregnancy, Animal; Pyridinium Compounds; Thrombocytopenia; Time Factors | 1990 |
[Antigen-induced biphasic eosinophil infiltration in the airways of actively sensitized guinea pigs and its inhibition by PAF antagonist and cyclosporin A].
Topics: Animals; Asthma; Bronchi; Cyclosporins; Eosinophilia; Guinea Pigs; Male; Ovalbumin; Platelet Activating Factor; Pyridinium Compounds; Time | 1990 |
[An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)].
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Constriction; Liver; Male; Mitochondria; Platelet Activating Factor; Portasystemic Shunt, Surgical; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock | 1990 |
[Bronchial hyperresponsiveness to histamine in guinea pig induced by intravenous administration of platelet activating factor].
Topics: Airway Resistance; Animals; Bronchi; Guinea Pigs; Histamine; Infusions, Intravenous; Male; Muscle Contraction; Muscle, Smooth; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds | 1990 |
The effect of platelet-activating factor on [14C]aminopyrine uptake by isolated guinea pig parietal cells.
Topics: Aminopyrine; Analysis of Variance; Animals; Calcium; Carbachol; Gastric Acid; Guinea Pigs; Histamine; In Vitro Techniques; Male; Parietal Cells, Gastric; Platelet Activating Factor; Pyridinium Compounds | 1990 |
Gastric hemodynamic disturbance induced by hemorrhagic shock in rats. Role of platelet-activating factor.
Topics: Animals; Gastric Mucosa; Hemodynamics; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reperfusion Injury; Shock, Hemorrhagic; Time Factors | 1990 |
Agonist and antagonist of oxygen free radical.
Topics: Cells, Cultured; Endotoxins; Humans; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Pyridinium Compounds; Temperature; Tetradecanoylphorbol Acetate; Verapamil | 1990 |
Effect of a platelet activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion.
Topics: Analysis of Variance; Animals; Blood Pressure; Hypotension; Ligation; Liver; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock | 1990 |
Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells.
Topics: Animals; Aorta, Thoracic; Blotting, Northern; Cells, Cultured; Endothelins; Endothelium, Vascular; Gene Expression; Humans; Indomethacin; Interleukin-1; Kinetics; Peptide Biosynthesis; Peptides; Platelet Activating Factor; Pyridinium Compounds; Recombinant Proteins; RNA, Messenger; Swine; Transcription, Genetic | 1990 |
Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
Topics: Alprostadil; Animals; Blood Pressure; Cathepsin D; Drug Therapy, Combination; Male; Myocardial Depressant Factor; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock, Traumatic; Time Factors | 1988 |
Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Topics: Animals; Blood Platelets; In Vitro Techniques; Molecular Weight; Phospholipid Ethers; Phosphoproteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Quinolines; Quinolinium Compounds; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetradecanoylphorbol Acetate; Thrombin; Type C Phospholipases | 1989 |
Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Topics: Animals; Blood Platelets; Enzyme Activation; In Vitro Techniques; Phosphatidylinositols; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Quinolines; Quinolinium Compounds; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Type C Phospholipases | 1989 |
Platelet-activating factor causes goblet cell depletion in the conjunctiva.
Topics: Animals; Capillary Permeability; Conjunctiva; Guinea Pigs; Histamine; In Vitro Techniques; Leukocytes; Leukotriene E4; Male; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; SRS-A | 1989 |
CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcimycin; Epoprostenol; Guinea Pigs; In Vitro Techniques; Macrophages; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritoneal Cavity; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1989 |
Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels.
Topics: Acetylcholine; Animals; Detergents; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Relaxation; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Splanchnic Circulation; Vascular Resistance | 1989 |
Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2.
Topics: Animals; Benzofurans; Calcium; Cells, Cultured; Endothelins; Endothelium, Vascular; Fluorescent Dyes; Fura-2; Male; Muscle, Smooth, Vascular; Peptides; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Thromboxane A2 | 1989 |
Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF).
Topics: Animals; Aspirin; Azepines; Blood Pressure; Death, Sudden; Dexamethasone; Diltiazem; Electrocardiography; Endothelins; Guinea Pigs; Hypertension; Hypotension; Male; Mice; Mice, Inbred ICR; Peptides; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Triazines; Triazoles | 1989 |
Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
Topics: Animals; Blood Pressure; Chemical Phenomena; Chemistry; In Vitro Techniques; Mice; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Rabbits; Rats; Structure-Activity Relationship | 1989 |
Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.
Topics: Animals; Blood Pressure; Capillary Permeability; Coronary Disease; Heart; Heart Rate; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains | 1988 |
Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
Topics: Animals; Blood Pressure; Cathepsin D; Male; Myocardial Depressant Factor; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock, Hemorrhagic | 1988 |
[Effect of a platelet activating factor (PAF) antagonist on the hepatic afferent vascular occlusion].
Topics: Animals; Hepatic Veno-Occlusive Disease; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains | 1988 |
CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Topics: Animals; Blood Platelets; Blood Pressure; Humans; Male; Mice; Mice, Inbred ICR; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Serotonin | 1987 |
Spatial heterogeneity of mucosal blood flow during ischemia-reperfusion injury of rat stomach investigated by laser Doppler perfusion imaging.
Topics: Analysis of Variance; Animals; Blood Flow Velocity; Gastric Mucosa; Hemodynamics; Ischemia; Laser-Doppler Flowmetry; Male; Microcirculation; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Reperfusion Injury; Stomach | 1995 |
Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
Topics: Animals; Cell Degranulation; Chemotaxis, Leukocyte; Eosinophils; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Neutrophils; Phenylpropionates; Platelet Activating Factor; Pyridinium Compounds; Skin Physiological Phenomena; Substance P | 1993 |
Role of leukotriene B4 in substance P-induced granulocyte infiltration in mouse skin.
Topics: Animals; Granulocytes; Leukotriene B4; Mast Cells; Mice; Mice, Inbred BALB C; Phenylpropionates; Platelet Activating Factor; Pyridinium Compounds; Skin; Skin Physiological Phenomena; Substance P | 1993 |
Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.
Topics: Animals; Azepines; Female; Guinea Pigs; Histamine; Male; Platelet Activating Factor; Pruritus; Pyridinium Compounds; Triazoles | 1995 |
Mechanism of the contractile response to platelet-activating factor (PAF) of the rat stomach fundus. I. PAF-induced contractile response and calcium mobilization.
Topics: Animals; Calcium; Gastric Fundus; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nicardipine; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 1993 |
Effect of platelet-activating factor on intracellular free calcium in cow tracheal epithelium.
Topics: Animals; Bradykinin; Calcium; Cattle; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Fura-2; Inositol 1,4,5-Trisphosphate; Platelet Activating Factor; Pyridinium Compounds; Trachea; Verapamil | 1994 |
Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells.
Topics: Chromatography, Thin Layer; Furans; Gas Chromatography-Mass Spectrometry; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Protein Precursors; Pyridinium Compounds; Saccharomyces cerevisiae | 1994 |
Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasmapheresis on cardiac xenograft survival.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Graft Survival; Heart Rate; Heart Transplantation; Plasmapheresis; Platelet Activating Factor; Pyridinium Compounds; Swine; Transplantation, Heterologous | 1994 |
Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances.
Topics: Animals; Bacterial Toxins; Enterotoxins; Escherichia coli; Free Radicals; Gastrointestinal Hemorrhage; Injections, Intra-Arterial; Intestine, Small; Laser-Doppler Flowmetry; Male; Microcirculation; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Shiga Toxin 1; Tissue Plasminogen Activator | 1994 |
Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
Topics: Analysis of Variance; Animals; Biological Assay; Creatine Kinase; Isoenzymes; Leukopenia; Macrophages; Male; Myocardial Ischemia; Myocardial Reperfusion; Necrosis; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 1993 |
Platelet-activating-factor-induced changes in cardiovascular function and oxyradical status of myocardium in presence of the PAF antagonist CV-6209.
Topics: Animals; Creatine Kinase; Dogs; Female; Free Radicals; Heart; Hemodynamics; Hydrogen-Ion Concentration; Lactates; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Contraction; Myocardium; Oxygen; Platelet Activating Factor; Pyridinium Compounds; Ventricular Function, Left | 1994 |
Early release of neutrophil chemotactic factor from isolated rat heart subjected to regional ischaemia followed by reperfusion.
Topics: Animals; Chemotaxis; Disease Models, Animal; Hot Temperature; Interleukin-8; Isoquinolines; Male; Myocardial Reperfusion Injury; Myocardium; Phenylpropionates; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Tetrahydroisoquinolines; Time Factors | 1993 |
Role of endothelin and platelet-activating factor in indomethacin-induced gastric mucosal injury in rats.
Topics: Animals; Endothelins; Gastric Mucosa; Gastritis; Immunization, Passive; Indomethacin; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley | 1993 |
Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Bile; Bile Ducts, Intrahepatic; Dose-Response Relationship, Drug; Ischemia; L-Lactate Dehydrogenase; Liver; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 1993 |
Platelet-activating factor (PAF) in male reproductive organs of guinea pigs and rats: effect of androgen on PAF in seminal vesicles.
Topics: Animals; Castration; Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Furans; Gene Expression Regulation; Genitalia, Male; Guinea Pigs; Male; Microscopy, Electron; Organ Size; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Rats; Rats, Wistar; Seminal Vesicles; Testosterone | 1993 |
Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.
Topics: Animals; Disease Models, Animal; Diterpenes; Female; Ginkgolides; Immunoglobulin G; Ischemic Attack, Transient; Lactones; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Subarachnoid Hemorrhage | 1993 |
Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion.
Topics: Animals; Blood Pressure; Heparin; Hypotension; Liver Circulation; Male; Platelet Activating Factor; Portal System; Pyridinium Compounds; Rats; Rats, Wistar; Splanchnic Circulation | 1993 |
Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid.
Topics: Animals; Blood Flow Velocity; Cell Adhesion; Edema; Eicosapentaenoic Acid; Endotoxins; Erythrocytes; Escherichia coli; Fatty Acids; Ileum; Intestinal Mucosa; Leukocytes; Male; Microcirculation; Phospholipids; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Venules | 1993 |
Effects of platelet activating factor on mouse embryo implantation in vitro.
Topics: Animals; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Embryo Implantation; Embryo Transfer; Embryo, Mammalian; Endometrium; Female; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Platelet Activating Factor; Pyridinium Compounds | 1995 |
Oxidative stress in gastric mucosal injury: role of platelet-activating factor-activated granulocytes.
Topics: Animals; Electric Stimulation; Fluoresceins; Free Radical Scavengers; Gastric Mucosa; Granulocytes; Luminescent Measurements; Male; Microcirculation; Microscopy, Fluorescence; Oxidative Stress; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Superoxide Dismutase | 1995 |
Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.
Topics: Animals; Ceruletide; Cholecystokinin; Gastrointestinal Agents; Hormone Antagonists; Laser-Doppler Flowmetry; Male; Pancreas; Platelet Activating Factor; Proglumide; Pyridinium Compounds; Rats; Rats, Wistar; Regional Blood Flow; Stimulation, Chemical; Time Factors | 1996 |
Mechanisms of desensitization of vasodilatation induced by platelet-activating factor in hypertensive rats.
Topics: Acetylcholine; Animals; Cyclic GMP; GTP-Binding Proteins; Hypertension; Hypertension, Renovascular; In Vitro Techniques; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Pertussis Toxin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Vasodilation; Virulence Factors, Bordetella | 1996 |
Arrhythmias caused by platelet activating factor.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Female; Lidocaine; Male; Membrane Potentials; Patch-Clamp Techniques; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrodotoxin | 1996 |
Thromboxane rather than platelet activating factor mediates pulmonary vasoconstriction after antigen challenge in rabbits.
Topics: Anesthesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Enzyme Inhibitors; Humans; Immunization; Indomethacin; Lung; Methacrylates; Platelet Activating Factor; Pulmonary Artery; Pulmonary Circulation; Pyridinium Compounds; Rabbits; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction | 1996 |
CV6209 inhibits airway wall thickening and airway hyperresponsiveness to histamine induced by intravenous administration of platelet-activating factor in guinea pigs.
Topics: Airway Resistance; Animals; Asthma; Bronchi; Guinea Pigs; Histamine; Histamine Antagonists; Lung; Male; Platelet Activating Factor; Pyridinium Compounds | 1996 |
Prednisolone, platelet-activating factor receptor antagonist, or superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation.
Topics: Acridine Orange; Animals; Antiviral Agents; Capillaries; Cell Adhesion; Cell Movement; Endothelium, Vascular; Fluorescein Angiography; Fluorescent Dyes; Fluorophotometry; Glucocorticoids; Leukocytes; Microcirculation; Platelet Activating Factor; Prednisolone; Pyridinium Compounds; Rats; Retinal Vessels; Superoxide Dismutase | 1997 |
Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Diterpenes; Dose-Response Relationship, Drug; Embryo, Mammalian; Fibrinolytic Agents; Fluorescent Dyes; Fura-2; Ginkgolides; Glutamic Acid; Immunoglobulin G; Lactones; Neurons; Neurotoxins; Platelet Activating Factor; Pyridinium Compounds; Rats | 1997 |
Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes.
Topics: Action Potentials; Animals; Dogs; Female; Heart; In Vitro Techniques; Male; Myocardium; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1997 |
Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists.
Topics: Animals; Blood Platelets; Calcimycin; Cell Communication; Complement C5a; Cytochalasin B; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Lipoxins; Male; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; Recombinant Proteins; Swine; Thromboxane A2 | 1997 |
Role of platelet-activating factor in two-kidney, one-clip hypertension.
Topics: Animals; Blood Pressure; Diacylglycerol Cholinephosphotransferase; Hypertension, Renovascular; Injections, Intravenous; Kidney Medulla; Male; Organ Size; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Renal Circulation | 1997 |
A platelet activating factor antagonist attenuates the effects of testicular ischemia.
Topics: Animals; Ischemia; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Spermatic Cord Torsion; Testis | 1997 |
Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line.
Topics: Azepines; Calcium; Cell Death; Cell Line, Transformed; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hippocampus; Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Signal Transduction; Triazoles | 1998 |
A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation.
Topics: Animals; Female; Heart; Heart Transplantation; Lung; Lung Transplantation; Organ Preservation; Platelet Activating Factor; Pyridinium Compounds; Respiratory Mechanics; Swine; Vascular Resistance | 1997 |
Inhibition of tumor necrosis factor-alpha production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages.
Topics: Acyltransferases; Animals; Azepines; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Furans; Imidazoles; Macrophages, Peritoneal; Male; Organophosphorus Compounds; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thapsigargin; Triazoles; Tumor Necrosis Factor-alpha | 1998 |
Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
Topics: Animals; Diterpenes; Ginkgolides; In Vitro Techniques; Lactones; Long-Term Potentiation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Synaptic Transmission; Vestibular Nuclei | 1998 |
Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung.
Topics: Animals; Antigens; Bronchoconstriction; Culture Techniques; Erythrocytes; Humans; Lung; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Pyridinium Compounds; Rabbits; Vasoconstriction | 1998 |
Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung.
Topics: Animals; Antibodies, Monoclonal; Capillaries; Capillary Permeability; Hydrogen Peroxide; Intercellular Adhesion Molecule-1; Ischemia; Leukocytes; Lung; Male; Oxygen; Platelet Activating Factor; Pulmonary Artery; Pyridinium Compounds; Rats; Rats, Wistar | 1998 |
Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
Topics: Anaphylaxis; Animals; Antibodies, Monoclonal; Cattle; Cyproheptadine; Female; Histamine H1 Antagonists; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Isoantibodies; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Nude; Piperazines; Platelet Activating Factor; Propranolol; Pyridinium Compounds; Serum Albumin, Bovine; Triprolidine | 1998 |
Strategies of myocardial protection for operation in chronic model of cyanotic heart disease.
Topics: Animals; Cardiopulmonary Bypass; Chronic Disease; Disease Models, Animal; Filtration; Heart; Heart Arrest, Induced; Heart Defects, Congenital; Injections, Intravenous; Lymphocyte Depletion; Myocardial Contraction; Platelet Activating Factor; Pyridinium Compounds; Swine | 1998 |
Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.
Topics: Eicosanoids; Eosinophils; Humans; Immunoglobulin G; Interleukin-5; Pertussis Toxin; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pyridinium Compounds; Superoxides; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella | 1999 |
Platelet-activating factor increases the expression of metalloproteinase-9 in human bronchial epithelial cells.
Topics: Bronchi; Cells, Cultured; Collagenases; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Matrix Metalloproteinase 9; Molecular Weight; Platelet Activating Factor; Pyridinium Compounds; RNA, Messenger | 1999 |
Possible participation of intracellular platelet-activating factor in tumor necrosis factor-alpha production by rat peritoneal macrophages.
Topics: Animals; Azepines; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Furans; Imidazoles; Indomethacin; Macrophages, Peritoneal; Male; Organophosphorus Compounds; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thapsigargin; Triazoles; Tumor Necrosis Factor-alpha | 1999 |
Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
Topics: Azepines; Cell Movement; Diterpenes; Dose-Response Relationship, Drug; Fibrinolytic Agents; Gene Products, tat; Ginkgolides; HIV-1; Humans; Lactones; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Triazoles; Tumor Cells, Cultured | 1999 |
Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release.
Topics: Animals; Azepines; Cell Death; Cell Line; Coculture Techniques; Dose-Response Relationship, Drug; Endothelium, Vascular; Macrophages, Peritoneal; Mice; Phagocytes; Phagocytosis; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Triazoles; Tumor Necrosis Factor-alpha | 2000 |
Lipid mediators stimulate reactive oxygen species formation in immortalized human keratinocytes.
Topics: Calcium; Cell Line; Ceramides; Diterpenes; Ginkgolides; Humans; Keratinocytes; Lactones; Lipid Metabolism; Lipids; Luminescent Measurements; Lysophosphatidylcholines; Membrane Lipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Reactive Oxygen Species; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction | 1999 |
Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats.
Topics: Animals; Apamin; Biological Factors; Blood Pressure; Charybdotoxin; Depression, Chemical; Endothelin-1; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 2000 |
Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
Topics: Arachidonate 5-Lipoxygenase; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; Down-Regulation; Humans; Immunosuppressive Agents; Indoles; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Solubility; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |
Leukotriene metabolism by intrapulmonary vessels of newborn lambs: effect of platelet-activating factor.
Topics: Animals; Animals, Newborn; Arachidonic Acid; Benzoquinones; In Vitro Techniques; Leukotriene B4; Leukotriene C4; Leukotriene D4; Leukotriene E4; Leukotrienes; Lipoxygenase Inhibitors; Muscle, Smooth, Vascular; Platelet Activating Factor; Pulmonary Artery; Pulmonary Veins; Pyridinium Compounds; Sheep | 2001 |
Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation.
Topics: Azepines; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Fatty Acids, Omega-3; Humans; Intercellular Adhesion Molecule-1; Monocytes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thienopyridines; Triazoles; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2002 |
Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures.
Topics: Animals; Arachidonic Acid; Astrocytes; Binding Sites; Cells, Cultured; Cerebral Cortex; Dinoprostone; Diterpenes; Drug Synergism; Female; Ginkgolides; Lactones; Osmolar Concentration; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds; Rats; Solvents | 2002 |
Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B).
Topics: Animals; Azepines; Cell Line; Female; Interleukin-1; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Platelet Activating Factor; Pyridinium Compounds; Receptors, Interleukin-1; Signal Transduction; Time Factors; Triazoles; Tumor Necrosis Factor-alpha | 2002 |
Structural determinants of blockade of eosinophil activation, adhesion and secretion by synthetic analogs of phomactin.
Topics: Cell Adhesion; Dose-Response Relationship, Drug; Eosinophils; Epoxy Compounds; Heterocyclic Compounds; Humans; Leukotriene C4; Platelet Activating Factor; Pyridinium Compounds; Structure-Activity Relationship; Superoxides | 2003 |
Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Calcimycin; Calcium; Colforsin; Corticosterone; Cyclic AMP-Dependent Protein Kinases; Diglycerides; Drug Synergism; Enzyme Activation; Guinea Pigs; Hydrocortisone; Ionophores; Isoquinolines; Male; Perfusion; Phospholipid Ethers; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Pyridinium Compounds; Receptors, G-Protein-Coupled; Secretory Rate | 2005 |
Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid.
Topics: Cell Adhesion; Cell Communication; Cells, Cultured; Diterpenes; Endothelium, Vascular; Ginkgolides; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Lactones; Linoleic Acids, Conjugated; Monocytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2006 |
Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70.
Topics: Anaphylaxis; Animals; HSP70 Heat-Shock Proteins; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Knockout; Platelet Activating Factor; Protozoan Proteins; Pyridinium Compounds; Toxoplasma; Toxoplasmosis, Animal | 2006 |
Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs.
Topics: Animals; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Central Nervous System; Electrophoresis; Encephalomyelitis, Autoimmune, Experimental; Female; Histamine Antagonists; Histamine H1 Antagonists; Immunoblotting; Immunoglobulin G; Intermediate Filament Proteins; Malate Dehydrogenase; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteomics; Pyridinium Compounds; Pyrilamine; Receptors, G-Protein-Coupled; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2007 |
Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
Topics: Apoptosis; Autoantibodies; Autoimmune Diseases; Blood Platelets; Cell Adhesion; Complement C3d; Culture Media, Conditioned; Fibrinogen; Humans; Immunoglobulin M; Immunosorbent Techniques; Leukocytes; P-Selectin; Platelet Activating Factor; Platelet Activation; Pyridinium Compounds; Recombinant Proteins; Thrombophilia; Thromboplastin; Vimentin | 2008 |
PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Topics: Anaphylaxis; Animals; Blood Pressure; Diphenhydramine; Histamine; Histamine H1 Antagonists; Hypotension; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, G-Protein-Coupled; Receptors, Histamine H1 | 2008 |
Anaphylaxis to a self-peptide in the absence of mast cells or histamine.
Topics: Adjuvants, Immunologic; Anaphylaxis; Animals; Bacterial Toxins; Bordetella pertussis; Encephalomyelitis, Autoimmune, Experimental; Glycoproteins; Histamine; Histidine Decarboxylase; Immunization; Immunoglobulin E; Interleukin-4; Mast Cells; Mice; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Platelet Activating Factor; Pyridinium Compounds; Th1 Cells; Th2 Cells | 2009 |
Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Topics: Anaphylaxis; Animals; Arterial Pressure; Cardiac Output; Diphenhydramine; Hemodynamics; Histamine; Hypotension; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, G-Protein-Coupled; Vascular Resistance; Vasoconstriction; Vasodilation | 2014 |